Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Terminated Phase 3 Interventional Results available

Pregabalin Versus Placebo In The Treatment Of Neuropathic Pain Associated With HIV Neuropathy

ClinicalTrials.gov ID: NCT01049217

Public ClinicalTrials.gov record NCT01049217. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 20, 2026, 1:03 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Multicenter Trial Of Pregabalin Versus Placebo In The Treatment Of Neuropathic Pain Associated With HIV Neuropathy (Pregabalin A0081244)

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The purpose of this study is to evaluate the efficacy of pregabalin compared to placebo in reducing neuropathic pain associated with HIV neuropathy.

Study identification

NCT ID
NCT01049217
Recruitment status
Terminated
Study type
Interventional
Phase
Phase 3
Enrollment
377 participants

Conditions and interventions

Conditions

Interventions

Drug

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Apr 2010 (Type not available)
Primary completion
May 2012 (Actual)
Completion
May 2012 (Actual)
Last update posted
Jan 28, 2021

2010 – 2012

United States locations

U.S. sites
25
U.S. states
8
U.S. cities
18
Facility City State ZIP Site status
Southwest Center for HIV/AIDS Phoenix Arizona 85006 —
SW Center for HIV/AIDS Phoenix Arizona 85006 —
Arizona Research Center Phoenix Arizona 85023 —
AIDS Research Alliance of America Los Angeles California 90015 —
Anthony Mills, MD, Inc. Los Angeles California 90069 —
David Geffen School of Medicine at UCLA c/o NNAB Los Angeles California 90095 —
Providence Clinical Research North Hollywood California 91606 —
Desert Medical Group, Inc. dba Desert Oasis Healthcare Medical Group Palm Springs California 92262 —
University of California San Diego San Diego California 92103 —
Stanford University Medical Center Stanford California 94305 —
Neuroscience Consultants, LLC. Aventura Florida 33180 —
South Florida Medical Research Aventura Florida 33180 —
The Kinder Medical Group Miami Florida 33133 —
Wohlfeiler, Piperato & Associates, LLC Miami Beach Florida 33139 —
Meridien Research Tampa Florida 33606 —
AIDS Research Consortium of Atlanta Atlanta Georgia 30308 —
Midtown Neurology, PC Atlanta Georgia 30312 —
Neurology Specialists of Decatur Research Center Decatur Georgia 30033 —
Rehabilitation Institute of Chicago Chicago Illinois 60611 —
Mount Sinai School of Medicine New York New York 10029 —
University of Toledo Medical Center Toledo Ohio 43614 —
University of Toledo Toledo Ohio 43614 —
University of Texas Physicians Bellaire Texas 77401 —
Amelia Court HIV Research Clinic Dallas Texas 75235 —
The University of Texas Medical School at Houston Houston Texas 77030 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 38 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT01049217, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jan 28, 2021 · Synced Oct 20, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT01049217 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →